Flash e-reader

 Go to e-reader chapter








Table 6.14

Unadjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

Level of HLA Mismatch 3 Months 1 Year 5 Years 10 Years
(Tx 2007 - 2008) (Tx 2007 - 2008) (Tx 2003 - 2008) (Tx 1998 - 2008)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 193 97.9% 1.0% 193 96.9% 1.2% 582 89.7% 1.5% 1,030 77.6% 2.1%
A Locus Mismatch 0 19 100.0% 0.0% 19 100.0% 0.0% 97 90.4% 3.1% 185 81.8% 4.1%
1 91 97.8% 1.5% 91 96.7% 1.9% 267 87.9% 2.3% 493 79.0% 2.7%
2 83 97.6% 1.7% 83 96.4% 2.0% 218 91.4% 2.4% 352 71.9% 4.5%
B Locus Mismatch 0 8 100.0% 0.0% 8 100.0% 0.0% 45 85.2% 5.6% 104 86.2% 3.9%
1 74 97.3% 1.9% 74 94.6% 2.6% 220 88.0% 2.6% 416 76.2% 3.3%
2 111 98.2% 1.3% 111 98.2% 1.3% 317 91.6% 1.8% 510 76.3% 3.2%
DR Locus Mismatch 0 15 100.0% 0.0% 15 100.0% 0.0% 62 92.9% 3.5% 128 76.0% 6.2%
1 85 98.8% 1.2% 85 96.5% 2.0% 272 89.9% 2.1% 480 80.0% 2.7%
2 93 96.8% 1.8% 93 96.8% 1.8% 248 88.6% 2.4% 421 76.8% 3.2%
Unknown 0 - - 0 - - 0 - - 1 0.0% 0.0%
Total Mismatch 0 2 100.0% 0.0% 2 100.0% 0.0% 10 78.8% 13.4% 22 73.9% 10.4%
1 0 - - 0 - - 16 87.5% 8.3% 42 80.6% 9.6%
2 15 100.0% 0.0% 15 100.0% 0.0% 55 91.8% 4.0% 120 85.4% 4.0%
3 30 100.0% 0.0% 30 96.7% 3.3% 117 90.9% 3.1% 225 79.1% 4.8%
4 61 96.7% 2.3% 61 95.1% 2.8% 151 88.2% 2.8% 238 75.2% 4.4%
5 50 98.0% 2.0% 50 98.0% 2.0% 154 88.8% 3.1% 250 75.4% 3.9%
6 35 97.1% 2.8% 35 97.1% 2.8% 79 93.3% 3.4% 132 75.6% 7.7%
Unknown 0 - - 0 - - 0 - - 1 0.0% 0.0%


Source: OPTN/SRTR Data as of October 1, 2010.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on pancreas and kidney-pancreas transplants.

Multi-organ transplants are excluded.